16:09 EST Cadrenal Therapeutics (CVKD) files to sell 590K shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVKD:
- Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
- Cadrenal Therapeutics Advances Tecarfarin Development
- Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
- Cadrenal Therapeutics raises $5.1M via at-the-market facility
- Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy